ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market.

Photo: One representative from a hospital shares his views at a symposium on AI for health hosted by World Internet ...

A paper warning of ‘substantial clinical risk’ from an overreliance on AI models makes a team of medical researchers a rare ...

An 1898 Supreme Court decision cemented the concept of birthright citizenship for children born in the U.S. to non-citizen ...

healthcare professionals could become overreliant on or uncritical of DeepSeek’s output. This could result in diagnostic errors or treatment biases, while more cautious clinicians could face the ...

The White House and congressional officials have been scrutinizing Apple's plan to strike a deal with Alibaba to make the ...

Nvidia and AMD stocks surged after landing major AI chip deals with Saudi Arabias Humain, a subsidiary of the Public ...

CITY 100, the inaugural smartphone in its brand-new CITY Series. itel CITY 100 redefines expectations for budget smartphones ...

The Invesco S&P 500 Equal Weight Technology ETF (RSPT) offers a more diversified and resilient approach compared to the ...

VNET saw 2025 volatility with AI-driven gains offset by tech sell-offs, solid earnings, and rising risks. Find out why VNET ...

Ready to unlock your full math potential? 🎓Subscribe for clear, fun, and easy-to-follow lessons that will boost your skills, build your confidence, and help you master math like a genius—one step at ...

The technological success that has captured the attention of many in the United States is one aspect of the Chinese economy.